133 related articles for article (PubMed ID: 28921938)
1. Prostate cancer treatment in renal transplant recipients: a systematic review.
Marra G; Dalmasso E; Agnello M; Munegato S; Bosio A; Sedigh O; Biancone L; Gontero P
BJU Int; 2018 Mar; 121(3):327-344. PubMed ID: 28921938
[TBL] [Abstract][Full Text] [Related]
2. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.
Hevia V; Boissier R; Rodríguez-Faba Ó; Fraser-Taylor C; Hassan-Zakri R; Lledo E; Regele H; Buddde K; Figueiredo A; Olsburgh J; Breda A
Eur Urol Focus; 2018 Mar; 4(2):153-162. PubMed ID: 29921544
[TBL] [Abstract][Full Text] [Related]
3. A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer.
Ventimiglia E; Seisen T; Abdollah F; Briganti A; Fonteyne V; James N; Roach M; Thalmann GN; Touijer K; Chen RC; Cheng L
Eur Urol Oncol; 2019 May; 2(3):294-301. PubMed ID: 31200844
[TBL] [Abstract][Full Text] [Related]
4. Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases?
Jang WS; Kim MS; Jeong WS; Chang KD; Cho KS; Ham WS; Rha KH; Hong SJ; Choi YD
BJU Int; 2018 Feb; 121(2):225-231. PubMed ID: 28834084
[TBL] [Abstract][Full Text] [Related]
5. Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis.
Park JW; Jang WS; Koh DH; Ham WS; Rha KH; Hong SJ; Choi YD
Yonsei Med J; 2018 Jul; 59(5):580-587. PubMed ID: 29869455
[TBL] [Abstract][Full Text] [Related]
6. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
[TBL] [Abstract][Full Text] [Related]
7. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study.
Pettenati C; Jannot AS; Hurel S; Verkarre V; Kreis H; Housset M; Legendre C; Méjean A; Timsit MO
Clin Transplant; 2016 Aug; 30(8):964-71. PubMed ID: 27251769
[TBL] [Abstract][Full Text] [Related]
9. Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?
Roach M; Ceron Lizarraga TL; Lazar AA
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1064-70. PubMed ID: 26581143
[TBL] [Abstract][Full Text] [Related]
10. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancer.
Lei JH; Liu LR; Wei Q; Yan SB; Song TR; Lin FS; Yang L; Cao DH; Yuan HC; Xue WB; Lv X; Cai YC; Zeng H; Han P
Sci Rep; 2015 Jan; 5():7713. PubMed ID: 25578739
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a prospective trial of trimodality therapy of weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate cancer with or without prior prostatectomy.
Hussain A; Wu Y; Mirmiran A; DiBiase S; Goloubeva O; Bridges B; Mannuel H; Engstrom C; Dawson N; Amin P; Kwok Y
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):167-74. PubMed ID: 21036487
[TBL] [Abstract][Full Text] [Related]
13. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Sedlmayer F; Wenz F; Zips D; Wiegel T;
Strahlenther Onkol; 2018 Jul; 194(7):619-626. PubMed ID: 29383406
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
15. Our experience in the management of prostate cancer in renal transplant recipients.
Narváez A; Suarez J; Riera L; Castells-Esteve M; Cocera R; Vigués F
Actas Urol Esp (Engl Ed); 2018 May; 42(4):249-255. PubMed ID: 29395386
[TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort.
Marra G; Soria F; Peretti F; Oderda M; Dariane C; Timsit MO; Branchereau J; Hedli O; Mesnard B; Tilki D; Olsburgh J; Kulkarni M; Kasivisvanathan V; Lebacle C; Rodriguez-Faba O; Breda A; Soeterik T; Gandaglia G; Todeschini P; Biancone L; Gontero P; On Behalf Of The Collaborators
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612184
[TBL] [Abstract][Full Text] [Related]
17. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting.
Berge V; Thompson T; Blackman D
Scand J Urol Nephrol; 2007; 41(3):198-203. PubMed ID: 17469027
[TBL] [Abstract][Full Text] [Related]
18. Low-dose-rate brachytherapy for prostate cancer in renal transplant recipients.
Rivero-Belenchón I; Osmán-García I; Congregado-Ruíz CB; Cabrera-Roldán P; Jiménez-Torres MJ; Baeza-Trujillo M; Lendínez-Cano G; Conde-Sánchez JM; Argüelles-Salido E; Ortiz-Gordilo MJ; Medina-López RA
Brachytherapy; 2018; 17(5):808-815. PubMed ID: 29970298
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
[TBL] [Abstract][Full Text] [Related]
20. Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.
Kunz I; Musch M; Roggenbuck U; Klevecka V; Kroepfl D
BJU Int; 2013 Mar; 111(3 Pt B):E24-9. PubMed ID: 22947135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]